Viemed Healthcare Announces Year End 2025 Earnings Conference Call Details

robot
Abstract generation in progress

This is a paid press release. Contact the press release distributor directly with any inquiries.

Viemed Healthcare Announces Year End 2025 Earnings Conference Call Details

Viemed Healthcare, Inc.

Tue, February 24, 2026 at 9:00 PM GMT+9 1 min read

In this article:

VMD

+0.61%

**LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / **Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Year End 2025 earnings conference call on Thursday, March 5, 2026, at 11:00 a.m. ET.

Interested parties may participate in the call by dialing:

877-407-6176 (US Toll-Free)

+1 201-689-8451 (International)

**Live Audio Webcast: **

Following the live call, a replay will be available in the Investor Relations section of the Company’s website at www.viemed.com.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is a provider of home medical equipment and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women’s health products and services. Viemed’s model emphasizes efficient, high-quality care delivered in the home through a combination of high-touch clinical support and technology-enabled services, including therapy, education, and counseling provided by our clinical practitioners. For more information, visit our website at www.viemed.com.

For further information, please contact:

Investor Relations
ir@viemed.com

Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
(337) 504-3802

**SOURCE: **Viemed Healthcare, Inc.

View the original press release on ACCESS Newswire

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin